Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
603392
Pozycja w akcjach
#3625
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical... Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical firm that handles the entire process from research and development to the production, marketing, and distribution of diagnostic solutions for infectious diseases and various vaccines. The company operates extensively across China and in international markets. Its comprehensive product range offers diagnostic test kits for a multitude of infectious agents, including COVID-19, HIV, HTLV, Hepatitis, EV-71, and Tuberculosis. It also provides specific detection reagents for Hepatitis C and Syphilis. Beyond these, the portfolio includes advanced diagnostic tools such as automated immunoassays, ELISA kits, rapid diagnostic tests, and various chemiluminescence, clinical chemistry, and general immunodiagnostic reagents. Furthermore, Beijing Wantai is a developer and supplier of vaccines for Hepatitis E and human papillomavirus (HPV). The company serves a wide array of clients, including blood banks, hospitals and clinics, specialized reference laboratories, border inspection centers, blood-processing companies, and scientific research institutes. Established in 1991, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is headquartered in China's capital city, Beijing.
Cena akcji
$3.71
Kapitalizacja rynkowa
$4.69B
Zmiana (1 dzień)
2.44%
Zmiana (1 rok)
-51.92%
Kraj
CN
Handel Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
Kategoria
Healthcare
Zyski dla Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
Zyski w Jun 2026 TTM: $-68.50M
Według najnowszych raportów finansowych Beijing Wantai Biological Pharmacy Enterprise Co., Ltd., obecny zysk firmy wynosi $-68.50M. W roku 2023 firma osiągnęła zysk w wysokości $196.85M, spadek w porównaniu do zysku z roku 2022, który wynosił $809.33M. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. od 2013 do 2026
Zyski na koniec każdego roku
| Rok | Zyski | Zmień |
|---|---|---|
| 2026 (TTM) | $-68.50M | -840.89% |
| 2024 | $9.25M | -95.30% |
| 2023 | $196.85M | -75.68% |
| 2022 | $809.33M | 121.33% |
| 2021 | $365.67M | 212.48% |
| 2020 | $117.02M | 275.84% |
| 2019 | $31.14M | -26.22% |
| 2018 | $42.20M | 53.78% |
| 2017 | $27.44M | 24.77% |
| 2016 | $21.99M | 8.94% |
| 2015 | $20.19M | -6.87% |
| 2014 | $21.68M | 27.42% |
| 2013 | $17.01M | 0.00% |
Zyski podobnych firm lub konkurentów
| Firma | Zyski | Różnica w zyskach | Kraj |
|---|---|---|---|
| $5.27B | -7,801.05% |
US
|
|
| $-3.09B | 4,406.84% |
US
|
|
| $-4.02B | 5,763.42% |
AU
|
|
| - | - |
CH
|
|
| $1.95B | -2,947.84% |
NL
|
